Changeflow GovPing Government & Legislation Grant Program for Ibogaine FDA Trials
Routine Rule Added Draft

Grant Program for Ibogaine FDA Trials

Favicon for changeflow.com State Bills: West Virginia
Detected April 1st, 2026
Email

Summary

West Virginia HB4626 proposes establishing a state grant program to fund clinical trials of ibogaine seeking FDA approval. The bill would provide financial support for research institutions and clinical investigators conducting ibogaine trials within the state, potentially expanding treatment options for substance use disorders and chronic pain conditions.

What changed

West Virginia House Bill 4626 proposes to create a new grant program specifically dedicated to funding ibogaine clinical trials pursuing FDA approval. The bill establishes a mechanism for state-supported research into this psychedelic-assisted therapy compound. Eligible recipients would include clinical investigators and research institutions conducting FDA-regulated trials in West Virginia.

Healthcare providers and research institutions should monitor HB4626's progress through the West Virginia legislature. If enacted, organizations conducting ibogaine research may need to apply for state grant funding to support trial activities. The bill may also require collaboration with state health agencies to establish program eligibility criteria and reporting requirements.

What to do next

  1. Monitor HB4626 legislative progress through West Virginia House committees
  2. Identify potential eligibility requirements for ibogaine research grant funding
  3. Evaluate institutional capacity to participate in FDA-regulated ibogaine trials

Source document (simplified)

SENATE PRESIDENT SENATORS COMMITTEES VIDEO/AUDIO DISTRICT MAPS SENATE CLERK SENATE RULES HOUSE SPEAKER DELEGATES COMMITTEES VIDEO/AUDIO DISTRICT MAPS HOUSE CLERK HOUSE RULES HOUSE STAFF JOINT INTERIM COMMITTEES LEGISLATIVE ADMINISTRATOR LEGISLATIVE SERVICES DIVISION PUBLIC INFORMATION LEGISLATIVE AUTOMATED SYSTEMS DIVISION LEGISLATIVE AUDITOR'S OFFICE PERFORMANCE EVALUATION & RESEARCH DIVISION POST AUDIT DIVISION BUDGET DIVISION REGULATORY AND FISCAL AFFAIRS DIVISION CLAIMS COMMISSION CRIME VICTIMS RULE-MAKING REVIEW SPECIAL INVESTIGATIONS JUDICIAL COMP. COMMISSION JOINT RULES STAFF INFO BILL STATUS BILL STATUS BILL TRACKING STATE LAW WEST VIRGINIA CODE ACTS OF THE LEGISLATURE CODE OF 1931 WV CONSTITUTION US CONSTITUTION REPORTS AGENCY REPORTS AGENCY GRANT AWARDS PERFORMANCE EVALUATIONS POST AUDITS EDUCATIONAL CITIZEN’S GUIDE INTERNSHIP PROGRAM PAGE PROGRAM PUBLICATIONS PHOTO GALLERY CAPITOL HISTORY HOW A BILL BECOMES LAW CONTACT SENATE ROSTER HOUSE ROSTER PUBLIC INFO. NEWS RELEASES HELPFUL LINKS

Select Bill Type Bill Resolution Select Year 2027 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982 1981 1980 1979 1978 1977 1976 1975 1974 1973 1972 1971 1970 1969 1968 1967 1966 1965 1964 1963 1962 1961 1960 1959 1958 1957 1956 1955 1953 1951 1949 1947 1946 1945 1944 1943 1941 1939 1937 1936 1935 1933 1932 1931 Select Session Regular Session First Special Session Second Special Session Third Special Session Fourth Special Session Fifth Special Session Sixth Special Session Seventh Special Session

Bill Status - 2026 Regular Session

| Search Bills by: | Bill Quick Search: | Bill Tracking: |
| All Bills (House | Senate)
All Resolutions
Subject
Short Title
Sponsor
Date Introduced
Code Affected
All Same As
Pending In Committee
Reported From Committee
Passed One Chamber
Fiscal Notes
Completed Legislation
Actions by Governor
View Public Comments | Enter Bill Number | Bill Tracking |

House Bill 4626

| | Legislative Session: 2026(RS) |
| LAST ACTION: | Completed Legislation |
| SUMMARY: | Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine |
| LEAD SPONSOR: | Browning |
| SPONSORS: | Worrell, Burkhammer, Dean, Hillenbrand, Hite, Heckert |
| BILL TEXT:
Bill Definitions | Enrolled Version - html | pdf | docx
Engrossed Version - html | pdf | docx
Introduced Version - html | pdf | docx |
| CODE AFFECTED: | §16 - 67 - 1 (New Code)
§16 - 67 - 2 (New Code)
§16 - 67 - 3 (New Code)
§16 - 67 - 4 (New Code)
§16 - 67 - 5 (New Code)
§16 - 67 - 6 (New Code)
§16 - 67 - 7 (New Code) |
| | |
| | |
| FISCAL NOTES: | Health, WV Department of |
| | |
| | |
| | |
| | |
| | |
| SUBJECT(S): | Health |

ACTIONS:
| | Description | Date | Journal Page |
| --- | --- | --- | --- |
| Completed Legislation | | | |
| H | To Governor 3/31/2026 | 03/31/26 | |
| H | House received Senate message | 03/13/26 | |
| S | Completed legislative action | 03/12/26 | |
| S | Communicated to House | 03/12/26 | 13 |
| S | Passed Senate (Roll No. 487) | 03/12/26 | 13 |
| S | Read 3rd time | 03/12/26 | 13 |
| S | On 3rd reading | 03/12/26 | |
| S | Read 2nd time | 03/11/26 | 79 |
| S | On 2nd reading | 03/11/26 | |
| S | Read 1st time | 03/10/26 | 102 |
| S | On 1st reading | 03/10/26 | |
| S | Reported do pass | 03/09/26 | 57 |
| S | To Finance | 02/18/26 | 11 |
| S | Reported do pass, but first to Finance | 02/18/26 | 11 |
| S | To Health and Human Resources | 01/30/26 | 4 |
| S | To Health and Human Resources then Finance | 01/30/26 | |
| S | Introduced in Senate | 01/30/26 | 4 |
| H | Communicated to Senate | 01/29/26 | |
| H | Passed House (Roll No. 32) | 01/29/26 | |
| H | Read 3rd time | 01/29/26 | |
| H | On 3rd reading, Special Calendar | 01/29/26 | |
| H | Read 2nd time | 01/28/26 | |
| H | On 2nd reading, Special Calendar | 01/28/26 | |
| H | Read 1st time | 01/27/26 | |
| H | On 1st reading, Special Calendar | 01/27/26 | |
| H | On 1st reading, Special Calendar | 01/26/26 | |
| H | Do pass | 01/23/26 | |
| H | Markup Discussion | 01/22/26 | |
| H | To House Health and Human Resources | 01/21/26 | |
| H | Introduced in House | 01/21/26 | |
| H | To Health and Human Resources | 01/21/26 | |
| H | Filed for introduction | 01/21/26 | |
Bill Status | Bill Tracking | Legacy WV Code | Bulletin Board | District Maps | Senate Roster | House Roster | Live | Blog | Jobs | Links | Home This Web site is maintained by the West Virginia Legislature's Office of Reference & Information. | Terms of Use |
Webmaster
|   © 2026 West Virginia Legislature **

Building House Bill 4626 PDF

Please wait for the document to be created. This may take a few seconds.

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
WV House
Instrument
Rule
Legal weight
Binding
Stage
Draft
Change scope
Substantive
Document ID
HB4626

Who this affects

Applies to
Healthcare providers Clinical investigators Patients
Industry sector
6211 Healthcare Providers 3254 Pharmaceutical Manufacturing
Activity scope
Clinical Trial Funding Drug Research FDA Clinical Trials
Geographic scope
US-WV US-WV

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Pharmaceuticals Public Health

Get Government & Legislation alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when State Bills: West Virginia publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.